Operating income before deduction of amortization: heartsciences.com (HSCS)
Heart Test Laboratories (HSCS) is attracting leading AI experts to process ECG data, which is defining the market vector. The consolidated EBITDA metric demonstrates profit dynamics, where the value of 0.00 characterizes this level. Heart Test Laboratories (HSCS) relies on third-party factories for circuit board assembly while retaining ownership of the algorithms, and the loyalty of top engineers is ensured by the high social significance of their developments.
HeartSciences (HSCS) - metric breakdowns and financial figures
- market value and analyst target forecast:
- company stock exchange capitalization indicators:
- balance sheet equity data:
- business debt structure and liquidity details:
All Debt to Shareholders' Equity Ratio Heart Test Laboratories|HSCS - Long-Term Debt to Capital|Current Liabilities to Capital Heart Test Laboratories, Inc.|HSCS - Company Aggregate Debts|Debts to Book Capitalization HeartSciences|HSCS - Company Long-Term Debt|Company Short-Term Loans and Borrowings HeartSciences|Intermediate Liquidity Ratio heartsciences.com
- company profitability and valuation multiples indicators:
HSCS - Net Income|Expected Net Income Heart Test Laboratories|HSCS - Price to Earnings Ratio|Market Cap to Future Earnings Ratio heartsciences.com|HSCS - PEG Multiple|Company Value to EBITDA HeartSciences|HSCS - Profit before payment of interest, taxes and amortization|Net earnings per share for the last four quarters HeartSciences|HSCS - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months heartsciences.com|HSCS - Net earnings per share growth this year|Expected earnings per share trend next year Heart Test Laboratories
Summary company analytics:HSCS (Heart Test Labs)
Absolute operating profit reflects the actual scale of cash generation before financial and tax obligations, allowing for an assessment of the fundamental efficiency of the core business. By analyzing the EBITDA of Heart Test Laboratories (HSCS), an investor separates the operational resilience of Heart Test Laboratories (HSCS) from the pressure of high pre-launch expenses and FDA regulatory delays, determining how effectively the company monetizes its technologies amid limited liquidity.
Competitors of Heart Test Laboratories (HSCS)
Agilent Corp (A) - Profit before interest, taxes and amortization|DGX - Profit before payment of interest, taxes and amortization|Operating income before deduction of amortization illumina.com ILMN|EXAS: Operating profit EBITDA|RVTY - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Bio-Rad Laboratories Inc|Anbio Corp (NNNN) - Operating income before deduction of amortization|Operating profit EBITDA SHC|QDEL (quidel.com) - Income before deduction of interest, taxes and amortization|Operating profit EBITDA OPK (OPKO Health)|CareDx Corp (CDNA) - Profit before interest, taxes and amortization|Maravai LifeSciences Corp - Operating profit EBITDA|FLGT - Operating profit EBITDA|Standard BioTools Inc. (LAB) - Profit before payment of interest, taxes and amortization|cytekbio.com - Income before deduction of interest, taxes and amortization|Operating profit before deduction of amortization OSUR|XGN (Exagen Diagnostics) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization MDXH (MDxHealth Inc.)|LUCD (Lucid Diagnostics, Inc) - Income before deduction of interest, taxes and amortization|Prenetics - Operating profit before deduction of amortization|Company profit before taxes, interest and amortization IMDX (Insight Molecular Diagnostics, Inc.)|Trinity Biotech Corp - Operating profit EBITDA|Profit before interest, taxes and amortization ProPhase Labs Inc|Ainos Corp (AIMD) - Profit before payment of interest, taxes and amortization|CODX - Operating income before deduction of amortization|Operating profit before deduction of amortization BMRA|CDIO (Cardio Diagnostics Holdings, Inc.) - Company profit before taxes, interest and amortization|Operating profit before deduction of amortization ONCO (Onconetix)|VRAX (Virax Biolabs Group Limited) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Bluejay BJDX|Aspira Women's Health Inc - Profit before payment of interest, taxes and amortization|Accelerate Diagnostics - Operating profit EBITDA|CNTG - Operating profit EBITDA|ENZ: Operating profit EBITDA|FRES (Fresh2 Group) - Profit before payment of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Genetic Technologies Ltd|Profit before interest, taxes and amortization 23andMe Inc ME|Profit before payment of interest, taxes and amortization Psychemedics (PMD)
